We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Credit Card-Sized Device Determines Blood Groups

By HospiMedica International staff writers
Posted on 17 May 2010
A simple credit card-sized device helps determine a person's blood group and Rhesus factor (Rh) status within minutes of submitting a blood sample.

The ABORhCard is a fully integrated, closed system, immune-hematology diagnostic platform that delivers a sample-to-result test to provide both ABO group and Rh blood type from a fingerstick blood sample. More...
The disposable, credit card sized device contains anti-A, anti-B, and anti-D antibodies printed into discrete microfluidic channels. Once the blood sample is applied, the test is performed with visible results available in less than one minute. The device can be stored at room temperature until needed, and a tube of buffer solution is included in the packaging to rehydrate the antibodies after prolonged storage.

The ABORhCard is a product of Micronics (Redmond, WA, USA), and was developed with funding by the U.S. army for use in battlefield and emergency situations. The device has been approved so far by the U.S. Food and Drug Administration (FDA) for personal educational and informational purposes only. It is not intended for blood bank processing of blood products, determining Rh status prior to administration of an immunoglobulin, or for screening purposes prior to blood transfusion.

"The introduction of the ABORhCard provides professionals with access to a credit card-sized device that makes it possible to determine a person's blood type and Rh status from a finger stick of whole blood, and it provides a visually-read result in minutes,” said Karen Hedine, president and CEO of Micronics.

Blood containing red cells with type A antigen on their surface contains serum antibodies against type B red cells. If, in transfusion, type B blood is injected into persons with type A blood, the red cells in the injected blood will be destroyed by the antibodies in the recipient's blood. In the same way, type A red cells will be destroyed by anti-A antibodies in type B blood. Type O blood can be injected into persons with type A, B, or O blood, unless there is incompatibility with respect to some other blood group system also present, such as Rhesus factor. Persons with type AB blood can receive type A, B, or O blood.

Related Links:

Micronics



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
Morcellator
TCM 3000 BL
Premium Air-Mattress
MA-51
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.